BV also alters cell shape, resulting in DNA and protein disintegration (Jung et al., 2018)
Current practice patterns extrapolated from animal studies and online communities typically involve subcutaneous injection of 0.25-0.5 mg once or twice daily, or oral administration of 0.5-1 mg daily to compensate for lower bioavailability
Johannsson declares that he has received speaking honoraria and grant support from the following companies: Novo Nordisk, Pfizer
The effect of administering B12 via IV varies from person to person
Unlike fat-soluble vitamins (A, D, E, and K) that can build up, B12 has a strong safety record and toxicity is rare
Among these, BPC-157, a synthetically produced peptide, has consistently generated significant interest, particularly within circles keenly focused on preclinical investigations into tissue repair and physiological modulation